Track topics on Twitter Track topics that are important to you
Winfield Associates Inc. boosted its position in shares of SPDR S&P Biotech by 38.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 9,995 shares of the exchange traded fund's stock after purchasing an additional 2,770 shares during the period.
Original Article: SPDR S&P Biotech (Xbi) Stake Raised by Winfield Associates Inc.NEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...